These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5298482)

  • 41. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Post-tuberculosis syndromes appearing in cases undergoing initial chemotherapy].
    Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):173-6. PubMed ID: 6273989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chemotherapy (therapy with secondary anti-tubercular agents). The specific agents and thin regimens].
    Yamamoto M; Nakamura H; Matsumoto M
    Saishin Igaku; 1966 Jan; 21(1):54-61. PubMed ID: 5965945
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 47. [The course of pulmonary tuberculosis in patients with primary resistance of Mycobacterium tuberculosis].
    Protopopova NM
    Probl Tuberk; 1966; 44(11):41-5. PubMed ID: 6002759
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on several factors affecting the judgment of chemotherapeutic efficiency in pulmonary tuberculosis. 3. Evaluation of the factors in the classification of the subjects (retreatment)].
    Mitsui Y
    Saishin Igaku; 1966 Mar; 21(3):568-76. PubMed ID: 5966045
    [No Abstract]   [Full Text] [Related]  

  • 49. [Significance of the mycobacterial resistance to antitubercular agents in the therapeutic results of treatments of polyresistant patients].
    Jancik E; Novák M; Feitová S; Jan ciková M; Tousek J
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):325-8. PubMed ID: 5897860
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R
    Kekkaku; 1968 Dec; 43(12):520-1. PubMed ID: 5716117
    [No Abstract]   [Full Text] [Related]  

  • 51. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 52. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 54. [Primary drug-resistance to principal antitubercular agents used in children].
    Bujko K; Zapaśnik-Kobierska MH; Maliszewska Z; Kostrzeński W
    Pediatr Pol; 1965 Aug; 40(8):773-80. PubMed ID: 5294914
    [No Abstract]   [Full Text] [Related]  

  • 55. [Exacerbation of pulmonary tuberculosis during chemotherapy].
    Karachunskii MA
    Probl Tuberk; 1996; (5):23-5. PubMed ID: 8984483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of the second chemotherapy trial of the IUAT. Bacteriological part.
    Lind A; Rist N
    Bull Int Union Tuberc; 1968 Dec; 41():178. PubMed ID: 5710246
    [No Abstract]   [Full Text] [Related]  

  • 57. [Retreatment of lung tuberculosis].
    Iwasaki T
    Naika; 1966 Sep; 18(3):487-93. PubMed ID: 5975918
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of tuberculosis due to resistant bacilli].
    Thibier R; Lepeuple A; Vivien JN
    Gaz Med Fr; 1965 Nov; 72(22):3895-902. PubMed ID: 5850524
    [No Abstract]   [Full Text] [Related]  

  • 59. [Late results of treatment of patients with drug resistant bacilli with ethionamide and other antitubercular agents].
    Pregowski W; Zagórecka A
    Gruzlica; 1968 Oct; 36(10):1047-9. PubMed ID: 5715457
    [No Abstract]   [Full Text] [Related]  

  • 60. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
    Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.